Literature DB >> 30204287

Cognitive deficits and psychopathological symptoms among children with medulloblastoma.

Annamária Szentes1, Nikoletta Erős1, Zoltán Kekecs2, Zsuzsanna Jakab1, Szabolcs Török3, Dezső Schuler1, Péter Hauser1, Miklós Garami1.   

Abstract

Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70-93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71-90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  IQ; cognitive outcomes; late effects; medulloblastoma; paediatric brain tumour; psychopathological symptoms

Mesh:

Substances:

Year:  2018        PMID: 30204287     DOI: 10.1111/ecc.12912

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

1.  Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.

Authors:  Ji Won Lee; Do Hoon Lim; Ki Woong Sung; Hee Won Cho; Hee Young Ju; Ju Kyung Hyun; Keon Hee Yoo; Hong Hoe Koo; Yeon-Lim Suh; Yoo-Sook Joung; Hyung Jin Shin
Journal:  Cancer Med       Date:  2020-06-30       Impact factor: 4.452

2.  Early Evidence of the Interplay between Separation Anxiety Symptoms and COVID-19-Related Worries in a Group of Children Diagnosed with Cancer and Their Mothers.

Authors:  Chiara Dotto; Maria Montanaro; Silvia Spaggiari; Valerio Cecinati; Letizia Brescia; Simona Insogna; Livia Zuliani; Paolo Grotto; Cristina Pizzato; Daniela Di Riso
Journal:  Children (Basel)       Date:  2022-04-01

3.  1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice.

Authors:  Kruttika Bhat; Paul Medina; Ling He; Le Zhang; Mohammad Saki; Angeliki Ioannidis; Nhan T Nguyen; Sirajbir S Sodhi; David Sung; Clara E Magyar; Linda M Liau; Harley I Kornblum; Frank Pajonk
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.